Acquisition of 48,000 units of loratadine oral liquid 5mg/5ml, box x bottle x 60 ML (minimum), 600,000 units of loratadine oral solid 10 mg, box x blister/strip, medications belonging to therapeutic group r (respiratory system) for the medical units of the M. I. Municipality of Guayaquil

This tender, identified by process code SIE-MIMG-2025-118-44856, is issued by the Municipality of Guayaquil for the acquisition of Loratadine medication. Specifically, the Municipality requires 48,000 units of Loratadine liquid oral suspension (5mg/5ml, 60ml bottle) and 600,000 units of Loratadine solid oral tablets (10mg, blister packs). These medications belong to therapeutic group R (Respiratory System). The estimated value for the solid oral Loratadine is USD 45,600.00. The procurement method is an Electronic Reverse Auction. This acquisition is crucial for ensuring the availability of essential respiratory medications within the Municipality's medical units, catering to the health needs of the population. The Municipality aims to secure a reliable supply of high-quality pharmaceuticals to support its public health services and provide necessary treatments to patients suffering from conditions requiring antihistamines like Loratadine.

This is a supplies contract in the governance and public administration sector. Located in Ecuador, Latin America, this opportunity is open to firms and consortiums.

Published through SERCOP Ecuador, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.